Accès à distance ? S'identifier sur le proxy UCLouvain
Health-Related Quality Of Life (Hrqol) Benefits Of Enzalutamide In Patients With Metastatic Castration-Resistant Prostate Cancer (Mcrpc): An In-Depth Analysis Of Eq-5d Data From The Prevail Trial.
Primary tabs
Document type | Communication à un colloque (Conference Paper) – Poster, Abstract |
---|---|
Access type | Accès restreint |
Publication date | 2015 |
Language | Anglais |
Conference | "IPSOR 18th Annual European Congress", Milan, Italy (du 07/11/2015 au 11/11/2015) |
Journal information | "Value in health" - Vol. 18, no.7, p. A475 (November 2015) |
Peer reviewed | yes |
issn | 1098-3015 |
e-issn | 1524-4733 |
Publisher | Elsevier (New York) |
Publication status | Publié |
Affiliations |
UCL
- SSS/IREC/CHEX - Pôle de chirgurgie expérimentale et transplantation UCL - (SLuc) Service d'urologie |
Links |
Bibliographic reference | Devlin, N ; Herdman, M ; Pavesi, M ; Phung, D ; Naidoo, S ; et. al. Health-Related Quality Of Life (Hrqol) Benefits Of Enzalutamide In Patients With Metastatic Castration-Resistant Prostate Cancer (Mcrpc): An In-Depth Analysis Of Eq-5d Data From The Prevail Trial..IPSOR 18th Annual European Congress (Milan, Italy, du 07/11/2015 au 11/11/2015). In: Value in health, Vol. 18, no.7, p. A475 (November 2015) |
---|---|
Permanent URL | http://hdl.handle.net/2078.1/166577 |